The survival of patients who have one lobe removed is related to the primary disease. After removal of a lobe for benign lesions, it does not affect the life expectancy of patients; after removal of a lobe for malignant lesions, the survival is related to the malignancy of the lesion and whether metastasis occurs, which cannot be generalized. For benign lesions such as pulmonary isolation, pulmonary cyst, pulmonary vascular malformation, etc., the removal of one lobe of the lung can be compensated by the adjacent lobe, which does not affect the life expectancy and does not reduce the quality of life of the patient. If lung cancer is resected at an early stage, the patient’s survival may be relatively long, but if lung cancer is more malignant or metastatic, the patient’s survival is short, and he or she may die in 1-2 years. In addition, after lung lobectomy, patients should pay attention to quit smoking and alcohol, avoid eating spicy food, and avoid exposure to odor stimulation such as perfume and gasoline to reduce coughing.